02879nas a2200217 4500000000100000008004100001260004400042653002400086653001700110653001900127653001500146100001300161700001400174700001300188700001300201245013400214856008100348490000700429520221100436022001402647 2020 d bSpringer Science and Business Media LLC 10 aInfectious Diseases 10 adeterminants 10 aonchocerciasis 10 aIvermectin 1 aAyalew F 1 aAtnafu DD 1 aBedimo M 1 aMulatu K 00 aDeterminants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study uhttps://tropmedhealth.biomedcentral.com/track/pdf/10.1186/s41182-020-00210-1 0 v48 3 aBackground
Onchocerciasis is an infection of a filarial worm which is endemic in Sub-Saharan Africa, including Ethiopia. Annual mass treatment with high coverage over for a long period of time should lead to a complete interruption of transmission and the ultimate elimination of the parasite. However, in Ethiopia, the required coverage levels were not achieved. Thus, the aim of this study was to identify the possible determinants of onchocerciasis treatment adherence in Assossa District.
Methods
A case-control study was conducted among 528 respondents (176 cases and 352 controls). Cases were respondents who took all five doses of treatments, and controls were those who took at most four does of ivermectin treatments (missed at least one or more doses). Structured questionnaire was used for data collection. Each possible factor for treatment adherence, with a P value < 0.2 obtained in the bi-variable logistic regression was entered into the multivariable logistic regression models to control the confounding factors. p value < 0.05 was used as cut-off-point for a variable to become a significant determinant of treatment adherence in multivariable logistic regression.
Results
Participation in selecting drug distributers [AOR = 2.7, 95%CI (1.7–4.1)], measuring height for dose determination [AOR = 3.6, 95%CI (1.9–6.7)], perceived risk of getting onchocerciasis [AOR = 2.1, 95%CI (1.6–2.7)], living near running water [AOR = 1.7, 95%CI (1.1–2.8)], and perceived needs of support for intake of ivermectin [AOR = 3.2, 95%CI(2.1–4.9)] were independent predictors for t treatment adherence.
Conclusions
Treatment adherence was influenced by participation in selecting drug distributers, measuring height for dose determination, perceived risk of getting onchocerciasis, living near running water and perceived needs of support for intake of ivermectin. To improve intake of the drug and its adherence, the community should be empowered to make decisions, and counseling family members and sensitizing those living far from river sides is commendable. Health information about onchocerciasis should be strengthening to increase risk perception. a1349-4147